The IL-15 receptor agonist N-803 combined with the anti-CD20 monoclonal antibody rituximab expands NK and CD8 T cells and alters single cell immune transcriptomes in a phase 1 clinical trial in lymphoma
Year: 2020
Type: conference-abstract
Source: The Journal of Immunology
Authors: Jennifer Ann Foltz-Stringfellow, Nancy L. Bartlett, Ethan McClain, Michelle Becker-Hapak, Brian T. Hess, Veronika Bachanova, Melissa M. Berrien-Elliott, Mark Foster, Timothy Schappe, Brad Kahl, Neha Mehta-Shah, Amanda F. Cashen, Kristin McDaniels, Chaz Moreno, Feng Gao, Obi Griffith, Malachi Griffith, Julia A. Wagner, Amy D. Rock, Patrick Soon-Shiong, John Lee, Allegra A. Petti, Todd A Fehniger
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4313368579